Αποτελέσματα Αναζήτησης
Central diabetes insipidus (CDI) is a clinical syndrome which results from loss or impaired function of vasopressinergic neurons in the hypothalamus/posterior pituitary, resulting in impaired synthesis and/or secretion of arginine vasopressin (AVP). ...
1 Αυγ 2013 · This article reviews the use of aspirin in people with diabetes as a primary and secondary CVD preventive measure. It summarizes current position statements related to the use of aspirin in this population and outlines the potential benefits and risks. Mechanism of Action and Potential Role in Diabetes Management.
20 Ιουλ 2021 · Both types of DI may be associated with hypernatraemia, and this may present as a medical emergency. Treatment goals are correction and stabilisation of water deficit and electrolyte balance, together with reduction in symptoms of excessive urinary water loss and thirst.
Cranial diabetes insipidus (CDI) is a treatable chronic condition that can potentially develop into a life-threatening medical emergency. CDI is due to the relative or absolute lack of the posterior pituitary hormone vasopressin (AVP), also known as anti-diuretic hormone.
Cranial diabetes insipidus (CDI) is a treatable chronic condition that can potentially develop into a life-threatening medical emergency. CDI is due to the relative or absolute lack of the posterior pituitary hormone vasopressin (AVP), also known as anti-diuretic hormone. AVP deficiency results in uncontrolled diuresis. Complete deficiency can lead
28 Φεβ 2019 · Intercurrent illness with hypernatraemia in a patient with diabetes insipidus should be managed as a medical emergency. Diabetes insipidus is a rare but treatable condition that typically presents with extreme thirst (polydipsia) together with the passing of large amounts of dilute urine (polyuria).
Treatment of diabetes insipidus or primary polydipsia depends on the underlying aetiology and differs in central diabetes insipidus, nephrogenic diabetes insipidus and primary polydipsia. This review will discuss issues and newest developments in diagnosis, differential diagnosis and treatment, with a focus on central diabetes insipidus.
